Maple Holdings Co., Ltd. announced private placement of 250 shares at a price of KRW 100,000,000 per share for gross proceeds of KRW 25,000,000,000 with new investor Eone Diagnomics Genome Center Co., Ltd. on July 19, 2021. The investor acquired 35.71% stake in the company. The transaction has been approved by the board of directors of investor.